0001292519-20-000002.txt : 20200428 0001292519-20-000002.hdr.sgml : 20200428 20200428161440 ACCESSION NUMBER: 0001292519-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200428 DATE AS OF CHANGE: 20200428 EFFECTIVENESS DATE: 20200428 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INVIVO THERAPEUTICS HOLDINGS CORP. CENTRAL INDEX KEY: 0001292519 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-365905 FILM NUMBER: 20825160 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BUILDING 1400 EAST 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-863-5524 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BUILDING 1400 EAST 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Design Source, Inc. DATE OF NAME CHANGE: 20040602 D 1 primary_doc.xml X0708 D LIVE 0001292519 INVIVO THERAPEUTICS HOLDINGS CORP. ONE KENDALL SQUARE Suite B14402 CAMBRIDGE MA MASSACHUSETTS 02139 617-863-5524 NEVADA Design Source, Inc. Corporation true Richard Toselli One Kendall Square Suite B14402 Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Richard Christopher One Kendall Square Suite B14402 Cambridge MA MASSACHUSETTS 02139 Executive Officer C. Ann Merrifield One Kendall Square Suite B14402 Cambridge MA MASSACHUSETTS 02139 Director Daniel Marshak One Kendall Square Suite B14402 Cambridge MA MASSACHUSETTS 02139 Director Christina Morrison One Kendall Square Suite B14402 Cambridge MA MASSACHUSETTS 02139 Director Richard Roberts One Kendall Square Suite B14402 Cambridge MA MASSACHUSETTS 02139 Director Robert Rosenthal One Kendall Square Suite B14402 Cambridge MA MASSACHUSETTS 02139 Director Biotechnology Decline to Disclose 06b false 2020-04-17 false true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 Park Avenue 4th Floor New York NY NEW YORK 10022 All States false 3022576 3022576 0 Private Placement of (i) warrants to purchase 1,715,240 shares of common stock at a purchase price of $1.62 per share and (ii) warrants to purchase 111,491 shares of common stock at a purchase price of $2.1875 per share false 8 255152 0 0 false INVIVO THERAPEUTICS HOLDINGS CORP. /s/ Richard Christopher Richard Christopher Chief Financial Officer 2020-04-28